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A b s tr a c t :  Q u erce tin  is a p o ly p h en o lic  flavono id . C o m m o n  sou rces in  the  d ie t are apples, 
o n ions, berries, and  red  w ine. E p id em io lo g ica l stud ies have  fo u n d  an in v erse  re la tio n sh ip  
b e tw een  d ie ta ry  q u e rce tin  in tak e  and  ca rd io v ascu la r d isease . T h is  has led  to  in vitro , 
in vivo, and  c lin ica l re search  to  d e term in e  the  m ech an ism  by  w h ich  q u erce tin  exerts  ca rd io ­
p ro tec tiv e  e ffec ts . R ecen t stud ies have  found  a red u c tio n  in  b lo o d  p ressu re  w h en  
h y p erten siv e  (> 140 m m  H g systo lic  and  >90  m m  H g d iasto lic ) an im als and  h u m an s are 
su p p lem en ted  w ith  quercetin . P ro p o sed  m ech an ism s fo r the  an tih y p erten siv e  e ffec t o f  
qu erce tin  in c lu d e  dec reased  ox id a tiv e  stress, in h ib itio n  o f  an g io ten sin  co n v ertin g  en zy m e 
ac tiv ity , im p ro v ed  en d o th e lia l func tion , d irec t ac tion  on the  v ascu la r sm ooth  m uscle, 
an d /o r m o d u la tio n  in  ce ll signaling  and  gen e  expression . A lth o u g h  in vitro  and  in vivo  
ev id en ce  ex ists  to  su pport and  re fu te  each  p o ssib ility , it is lik e ly  th a t q u erce tin  in flu en ces 
m u ltip le  ta rg e ts  v ia  a co m b in a tio n  o f  k n o w n  and  as y e t u n d isco v ered  m echan ism s. T he 
p u rp o se  o f  th is  rev iew  is to  ex am in e  the  m ech an ism s w h ereb y  q u erce tin  m ig h t red u ce  
b lo o d  p ressu re  in  h y p erten siv e  ind iv idua ls .
K e y w o rd s : querce tin ; h y p erten sio n ; an g io ten sin  co n v ertin g  enzym e; en d o th e lia l func tion ; 
an tio x id an ts
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1. In t ro d u c t io n
T h e A m erican  H eart A sso c ia tio n  estim ates th a t 80 m illio n  A m erican s cu rren tly  su ffe r from  
essen tia l h y p erten sio n  [1]. T h e  p a th o g en esis  and  p a th o p h y sio lo g y  o f  h y p erten sio n  is a com p lex  
h e te ro g en eo u s d iso rd er th a t can  co -ex is t w ith  o th er ca rd io v ascu la r and  m etab o lic  abnorm alities . I t is 
defin ed  as systo lic  b lo o d  p ressu re  co n sis ten tly  o v e r 140 m m  H g and  d iasto lic  b lo o d  p ressu re  over 
90 m m  H g and  rep resen ts  p ers is ten tly  e lev a ted  v ascu la r re s is tan ce , y e t h y p erten sio n  is u su a lly  
asy m p to m atic  [ 1].
B lo o d  p ressu re  (B P ) is co n tro lled  by  n eu ra l and  h u m o ral m echan ism s. N eu ra l reg u la tio n  is ca rried  
ou t by  the  au tonom ic  nerv o u s system  w h e reas  h u m o ra l reg u la tio n  is p e rfo rm ed  by  a v arie ty  o f 
substances re leased  by  d iffe ren t ce ll types [2]. H y p erten sio n  is la rg e ly  due to  in ap p ro p ria te  h u m o ra l 
co n tro l [2] p rec ip ita ted  by  in creased  ox id a tiv e  stress, in c reased  p ro d u c tio n  o f  endo thelin -1  (E T -1), 
decreased  n itric  ox ide  (N O ) p ro d u c tio n  an d /o r b io av a ilab ility , an d /o r o v er-s tim u la tio n  o f  the  ren in - 
an g io ten sin  system  (R A S). M o reo v er, th ese  changes have  b een  asso c ia ted  ca rd io v ascu la r d isease  
(C V D ) [2 -8 ] and  th ere  is a p o sitiv e  and  d irec t co rre la tio n  b e tw een  h y p erten sio n  and  risk  fo r ca rd iac  
arrhy thm ia , ca rd iac  h y p ertro p h y , m y o card ia l in farc tion , and  h ea rt fa ilu re  [1,9].
T rea tm en t o f  h y p erten sio n  dep en d s on the e tio lo g y  o f  the  d isease  and  in c lu d es  d ie t a ltera tions, 
w e ig h t loss, exerc ise , and  p h arm aco lo g ica l in terv en tio n s. P h arm aco lo g ica l th e rap ies  [e.g., an g io ten sin  
co n v ertin g  en zy m e (A C E ) in h ib itio n , d iu retics , and  ca lc iu m  ch an n e l b lockers] th a t ex is t to  trea t 
h y p erten sio n  are su ccessfu l b u t m ay  be asso c ia ted  w ith  n eg a tiv e  side e ffec ts  such  as p ers is ten t cough , 
d ry  th roat, a llerg ic  reac tio n s, d izz iness, ang io ed em a, and  k id n ey  fa ilu re  [10]. L ifesty le  in te rv en tio n s  
such  as red u ced  sod ium  in take, the  A m erican  H eart A sso c ia tio n  D A S H  (D ie ta ry  In terv en tio n s to  S top 
H y p erten sio n ) D iet, and  in c reased  p h y sica l ac tiv ity  are also  k n o w n  to lessen  the  severity  o f  
h y p erten sio n  [1]. In  ad d itio n  to  the  a fo rem en tio n ed  trad itio n a l th erap ies, d ie ta ry  supp lem en ts, also  
k n o w n  as n u traceu tica ls , are beco m in g  in creasin g ly  p o p u la r in  the  trea tm en t and  p rev en tio n  o f 
hy p erten sio n . In c reased  su p p lem en t use, in  gen era l, to  trea t m ed ica l co n d itio n s m ay  be  due to  an 
in ab ility  to  m ain ta in  lifes ty le  ch an g es as w e ll as a d esire  to  decrease  u se  o f  p h arm aceu tica ls ; how ever, 
m an y  supp lem en ts have  u n k n o w n  efficacy , safety , and  m ech an ism s o f  action . R ecen tly  th ere  has been  
an  ab u n d an ce  o f  re search  ex am in in g  d ie ta ry  p h y to ch em ica l supp lem en ts, such  as q u erce tin , and  th e ir 
effec t(s) on  v ascu la r health . T he p u rp o se  o f  th is  rev iew  is to  ex am in e  m ech an ism s by  w h ich  
su p p lem en ta l q u erce tin  red u ces  B P  in  h y p erten siv e  ind iv idua ls .
2. Q u e rc e t in
P h y to ch em icals , o r p h y to n u trien ts , are b io lo g ica lly  ac tive  p lan t co n stitu en ts  th a t o ccu r n a tu ra lly  to 
p ro tec t ag a in s t in sec t in v asio n , d isease , and  in fec tion . P h y to ch em ica ls  also  p ro v id e  co lo r, flavo r, and 
arom a. F lav o n o id s  are a specific  c lass o f  p h y to ch em ica ls  w h ich  are d iv id ed  in to  m ore th an  10 d iffe ren t 
subclasses b ased  on  th e ir m o lecu la r structure . T h e  structu re  o f  the  flav o n o id  also  de term in es p articu la r 
co n trib u tio n s to  the  h ea lth  b en efits  asso c ia ted  w ith  fru it and  v eg e tab le  co n su m p tio n  [11]. Q u erce tin  is 
a ph y to ch em ica l b e lo n g in g  to  the  flav o n o id  fam ily  and  is the  m o st u b iq u ito u s o f  the  d ie tary  
flavono ids. A p p les  and  on ions are p rim ary  sou rces in  the  w este rn  d iet; o th er fo o d s co n ta in in g  
qu erce tin  in c lu d e  c itru s  fru its , berries, red  g rapes, red  w ine, b rocco li, b a rk  roo ts , flo w ers , and  tea  
(T ab le  1). T he av erag e  w este rn  d ie t supp lies 1 5 -4 0  m g o f  q u erce tin  a day  and  h ig h er d ie ta ry  levels
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(> 33 m g/day) have  b een  asso c ia ted  w ith  d ecreased  risk  o f  C V D  [1 2 -1 4 ]. B ecau se  o f  the  h igh  
v ariab ility  in  flav o n o id  co n ten t o f  any  g iv en  food  due to  soil, harvest, and  sto rage cond itions; 
q u an tify in g  d ie ta ry  q u erce tin  in tak e  p rec ise ly  is ex trem ely  d ifficu lt [15 ,16]. Q u erce tin  is a lso  ava ilab le  
o v er the  co u n te r in  the  fo rm  o f  sup p lem en ts th a t can  co n ta in  up to  2 5 0 -1 ,5 0 0  m g querce tin . T hese  
la rg e  doses are u sed  to  h o m eo p a th ica lly  “trea t” a v arie ty  o f  ailm ents such  as allerg ies, asthm a, 
b ac te ria l in fec tio n s, a rth ritis , gou t, eye d iso rders, hy p erten sio n , and  n eu ro d eg en era tiv e  d isorders. 
B ecau se  few  co n tro lled  ran d o m ized  tria ls  have  b een  perfo rm ed , little  d ata  ex is t to  p ro v id e  a so lid  
sc ien tific  basis  fo r th ese  trea tm en t claim s.
T a b le  1. A m o u n t o f  qu erce tin  in  se lec ted  foods, ad ap ted  from  the  U S D A  datab ase  [17].
F o o d Q u e rc e t in  C o n te n t
C apers
O nions
C o co a  p o w d er
C ranberries
L in g o n b erries
A pp les
G reen  tea
B lack  tea
C atsup
233 m g /100  g
2 2 .0  m g /1 0 0  g
2 0 .0  m g /1 0 0  g
14.0 m g/100  g 
7 .4  m g /100  g 
4 .57 m g/100  g 
2.69 m g/100g  
1.99 m g/100g  
0 .8 6  m g /1 0 0  g
B ioavailability o f  Quercetin
T h e b io av a ilab ility  o f  qu erce tin  depends on the  ab so rp tio n  and  m etab o lism  o f  th is  flavono id . 
A b so rp tio n  is d ep en d en t up o n  the  ty p e  in g ested  (e .g ., q u erce tin  ag lycone  o r qu erce tin  g ly co sid es), the 
fo o d  m atrix  in  w h ich  it is found , and  in d iv id u a l d iffe rences in  co lo n  flo ra  [1 5 ,1 6 ,1 8 -2 4 ]. T he chem ical 
s tructu re  o f  p u re  qu erce tin  is an  u n -co n ju g a ted  ag ly co n e  (F igure  1). Q u erce tin  g ly co sid es  
(F igure  2) h av e  a ca rb o h y d ra te  m o ie ty  and  are m ore co m m o n ly  found  in  fo o d s [25]. S u pp lem en ts are 
sold  in  bo th  fo rm s and  stud ies in d ica te  th a t bo th  are read ily  b io av a ilab le  [1 8 ,1 9 ,2 2 -2 4 ,2 6 ]. W e have  
fo u n d  th a t h ea lth y  m ales g iv en  a sing le dose o f  1,095 m g q u erce tin  ag ly co n e  show  a s ig n ifican t 
in crease , fro m  base line , in  p lasm a qu erce tin  and  qu erce tin  m etab o lite  co n cen tra tio n  a fte r on ly  3 hours 
(0 .37 ±  0 .04  (j,M ra . 1.05 ±  0 .16  |aM P  <  0 .05). A d d itio n ally , w e observed  th a t p lasm a co n cen tra tio n s  
w ere  m ax im al (2 .33 ± 0 .72 (iM ) 10 ho u rs  a fte r in g estio n , and  re tu rn ed  to  b ase lin e  w ith in  24 hours 
(0 .45 ±  0 .06 pM ) (P  <  0 .05) [27],
Q u erce tin  is ab so rb ed  in  the  sm all in testin e  and  co lo n  w h ere  it and  its  g ly co sid es  are  co n ju g ated  
w ith  g lu cu ro n ic  ac id  in  the  in testin a l ep ithelium . I t is th en  b o u n d  to  a lbum in  and  tran sp o rted  to  the 
liv e r [11]. V ery  little  free  qu erce tin  is fo u n d  in  c ircu la tio n , and  m o st appears in  the  b lo o d  in  
g lu cu ro n id e  fo rm  and  as q u erce tin  m etab o lites  (iso rham netin  and  k aem p fero l) [21]. D esp ite  the 
po ten tia l p h y sio lo g ica l s ig n ifican ce  o f  q u erce tin  in  its  m etab o lized  fo rm , m uch  in  v itro  re search  has 
ex am in ed  qu erce tin  in  a fo rm  th a t w o u ld  n o t be  p re sen t in vivo  (see “D irec t ac tion  on  the  V S M ” ).
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F ig u re  1. Q u erce tin  ag lycone .
OH
OH 0
F ig u re  2 . C o n ju g ated  qu erce tin  (ru tin ).
OH
3. Q u e rc e t in :  A  T r e a tm e n t  f o r  H y p e r te n s io n ?
3.1. Effects o f  Quercetin on B P  in A nim als
O u r lab o ra to ry  and  o th ers  h av e  rep o rted  th a t q u erce tin  d ec reases  B P  an d /o r red u ces  the  sev e rity  of 
h y p erten sio n  in  sp o n tan eo u sly  h y p erten siv e  ra ts  (SH R ) [28 ,29], ra ts  fed  a h ig h -fa t h ig h -su cro se  d iet 
[30], ra ts  d efic ien t in  N O  [31], ra ts  in fu sed  w ith  an g io ten sin  [32], ra ts  w ith  aortic  co n stric tio n  [33], 
and  D ah l sa lt sensitive  ra ts  [34]. Q u erce tin  has also  b een  show n  to hav e  in  v itro  v aso d ila to r e ffec ts  in  
iso la ted  ra t arte ries [35,36]. W h ile  tran sla tin g  re su lts  observed  in  an im als d irec tly  to  h u m an s shou ld  be 
done w ith  cau tion , th ese  stud ies n ev e rth e less  p ro v id e  p ro o f  o f  p rin c ip le  th a t a q u erce tin -in d u ced  
red u c tio n  in  B P  m ig h t be  re sp o n sib le  fo r  the  red u c tio n  o f  C V D  risk  o b serv ed  in  hu m an s w ith  h igh  
qu erce tin  diets.
3.2. Effects o f  Quercetin on BP  in H um ans
E p id em io lo g ica l stud ies h av e  found  an in v erse  re la tio n sh ip  w ith  flav o n o id  in tak e  and  ch ron ic  
d isease  [1 2 -1 4 ]. E v id en ce  fro m  the  Z u tp h en  E ld erly  S tudy  [13] suggests  a s trong  ca rd io -p ro tec tiv e  
e ffec t o f  several flav o n o id s , in c lu d in g  quercetin . In  th is  study  the  risk  o f  co ro n ary  dea th  w as 
red u ced  by  as m u ch  as 6 8 % in  m en  w ho  co n su m ed  >29  m g flav o n o ls /d ay  co m p ared  to  m en  w ho
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co n su m ed  < 10  m g flav o n o ls /d ay . W h ile  the  specific  asso c ia tio n  b e tw een  qu erce tin  in tak e  and  B P  w as 
n o t ex am in ed  in  th is  study, the  au thors d id  rep o rt an  in v erse  re la tio n sh ip  b e tw een  h ig h  q uercetin - 
co n ta in in g  foods and  B P  [13].
S u p p lem en ta tio n  o f  the  d ie t w ith  qu erce tin  has been  show n  to red u ce  B P  in  h y p erten siv e  
in d iv id u a ls . W e co n d u c ted  a ran d o m ized , doub le-b lin d , p laceb o -co n tro lled  c ro sso v e r tria l u sin g  stage 
1 h y p erten siv e  (n = 22) and  p reh y p erten siv e  (n = 19) p a rtic ip an ts  to  in v estig a te  the  e fficacy  o f 
qu erce tin  supp lem ents. R ed u c tio n s (p <  0 .01) in  systo lic  ( -7  ±  2 m m  H g), d iasto lic  ( -5  ±  2 m m  H g), 
and  m ean  arte ria l B P  ( -5  ±  2 m m  H g) w ere  observed  in  stage 1 h y p erten siv e  m en  and  w o m en  afte r 
su p p lem en ta tio n  w ith  730  m g q u e rce tin / day  fo r 28 days vs. p laceb o  trea tm en t (F igu re  3). R ed u ctio n s  
o f  th is  m ag n itu d e  are c lin ica lly  re lev an t and  asso c ia ted  w ith  a 14% and 9%  decrease  in  m o rta lity  from  
stroke and  co ro n ary  h ea rt d isease , re sp ec tiv e ly  [1]. In  th is  study, qu erce tin  d id  n o t ev o k e  B P  
red u c tio n s  in  p re -h y p erten siv e  in d iv id u a ls  (n = 19) (F igure  3) [37]. T h is  la tte r  fin d in g  ag rees w ith  
o th er stud ies th a t rep o rt qu erce tin  does n o t lo w er B P  in  p re -h y p erten siv e  o r n o rm o ten siv e  in d iv id u a ls  
o r an im al m odels [27 ,29 ,31 ,38]. T h e  ab ility  o f  qu erce tin  to  lo w er B P  in  h y p erten siv e  b u t no t 
p reh y p erten siv e  o r n o rm o ten siv e  m o d els is n o t u n iq u e  to  th is  flavono id . F o r ex am p le , the B P  low ering  
e ffec t o f  a d ie t rich  in  fru its  and  v eg e tab les  in  h y p erten siv e  p a tien ts  is w e ll k now n; how ever, no 
red u c tio n  in  B P  is o b serv ed  in  n o rm o ten siv e  sub jects  a fte r a s im ilar d ie ta ry  in te rv en tio n  [39].
In  co n tra st to  the  a fo rem en tio n ed  stud ies, a re cen t study  by  E g ert et al., [40] fo u n d  qu erce tin  
red u ced  B P  in  o v erw eig h t and  obese  p reh y p erten siv e  ( > 1 2 0 -1 3 9  m m  H g systo lic  and  > 8 0 -8 9  m m  H g 
d iasto lic ) in d iv id u a ls  (N  = 93); SB P  w as red u ced  by  2 .9  ±  9.5 m m  H g a fte r 150 m g/d ay  q u erce tin  fo r 6 
w eek s (P  <  0 .05). D isc rep an c ies  in  the  e ffec t o f  qu erce tin  on p reh y p erten siv es  in  the  study  by  E g ert 
et al. and  o u r study, w h ich  rep o rted  no red u c tio n  in  B P  in  p reh y p erten siv es , m ig h t re su lt from  the 
lo n g e r d u ra tio n  o f  su p p lem en ta tio n  (e .g ., 42  d vs. 28 d) and  /  o r the  g rea te r n u m b er o f  sub jects 
(n = 93 vs. 19), re sp ec tiv e ly . W ith  reg ard  to  the  la tte r po in t, a la rg e r sam ple size in creases  sta tis tica l 
p o w er and  thus the  ab ility  to  d e tec t sm alle r ch an g es in  BP.
F ig u re  3 . R ed u ctio n  o f  B P  fro m  b ase lin e  in  qu erce tin  and  p laceb o  trea ted  subjects. D a ta  









□  Placebo ■  Quercetin
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4. P o te n t ia l  M e c h a n is m s  fo r  B lo o d  P re s s u re  R e d u c tio n
E v id en ce  ex is ts  to  su p p o rt several po ten tia l m ech an ism s w h ereb y  qu erce tin  m ig h t red u ce  B P  and  
d ecrease  the  severity  o f  h y p erten sio n  in  an im als and  hum ans. F o r ex am p le , qu erce tin  m ig h t red u ce  
o x id a tiv e  stress, in te rfe re  w ith  the  R A S , and  /o r  im p ro v e  en d o th e lia l an d /o r v ascu la r function .
4.1. O xidative Stress
In  the  past, the  m ech an ism  fo r q u erce tin -in d u ced  B P  red u c tio n  in  h y p erten siv e  an im als and  hum ans 
has been  a ttrib u ted  to  a red u c tio n  in  ox id a tiv e  stress. A n im al stud ies th a t have  o b serv ed  red u ced  B P  
afte r q u erce tin  su p p lem en ta tio n  h av e  also  show n im p ro v em en ts  in  o x id an t status, such  as red u c tio n  in  
p lasm a lip id  p ero x id es  [2 9 -3 1 ] and  u rin ary  iso p ro stan es  [29] w h en  co m p ared  to  u n trea ted  an im als. It 
w as h y p o th esized  th a t im p ro v em en t in  o x id an t status w as the  u n d erly in g  m ech an ism  b eh in d  im p ro v ed  
v ascu la r fu n c tio n  o bserved  in  th ese  stud ies [2 9 -3 1 ].
In  con trast, h um an  in v estig a tio n s, have  n o t c lea rly  and  co n sis ten tly  d em o n stra ted  an  an tio x id an t 
e ffec t o f  querce tin , even  w h en  using  re la tiv e ly  h ig h  doses [19 ,26 ,37]. F o r exam ple , E g e rt et al. [19], 
d em o n stra ted  th a t 2  w eeks o f  qu erce tin  su p p lem en ta tio n  in  h ea lth y , n o rm o ten siv e  in d iv id u a ls  d id  no t 
a ffec t p lasm a ox id ized  L D L , fe rric  red u cin g  an tio x id an t p o ten tia l (F R A P ), o r o x y g en  rad ica l 
ab so rb an ce  cap acity  (O R A C ). L ikew ise , w e have  fo u n d  sim ilar re su lts  a fte r 4  w eek s o f  730  m g/day  
qu erce tin  su p p lem en ta tio n  in  p re -h y p erten siv e  and  stage 1 h y p erten siv e  in d iv id u a ls  [37]. In  o u r study  
w e o b serv ed  sim ilar leve ls  o f  p lasm a an tio x id an t cap ac ity  and  u rin ary  iso p ro stan e  co n cen tra tio n  in  the 
qu erce tin  and  p laceb o  trea tm en t, reg ard less  o f  any  ch an g e  in  b lo o d  p ressu re  ev o k ed  by  qu erce tin  
su p p lem en ta tio n  [37]. In  co n trast, a la te r s tudy  by  E g ert et al. [38] ex am in ed  obese  and  o v erw eig h t 
in d iv id u a ls  w ith  m etab o lic  syndrom e fo u n d  red u c tio n s in  B P  acco m p an ied  by  lo w er o x id ized  L D L  
afte r 6 w eek s o f  daily  q u erce tin  su p p lem en ta tio n  w hen  co m p ared  to  b ase lin e  (p <  0 .0 0 1 ) and  p lacebo  
va lu es (p <  0 .05). H ow ever, th ere  w as no  d iffe ren ce  in  p lasm a an tio x id an t capacity .
W h ile  a g rea t deal o f  ev id en ce  o b ta in ed  fro m  h y p erten siv e  an im al m o d els in d ica tes  th a t qu erce tin  
m ig h t be  e ffec tiv e  in  low ering  o x id an t load , av a ilab le  da ta  from  hu m an s is equ ivocal. In  general, 
h ig h e r doses o f  qu erce tin  have  b een  ev a lu a ted  in  an im als v s . hum ans, and  th is  m ay  lead  to  s ig n ifican t 
d iffe ren ces  in  the  in trace llu la r co n cen tra tio n s o f  querce tin , and  su b seq u en t an tio x id an t e ffec ts . F o r 
exam ple , w e  h av e  p rev io u sly  observed  red u c tio n s  in  liv er m alo n d ia ld eh y d e  leve ls  in  qu erce tin  
su p p lem en ted  ra ts  (150 m g q u erce tin /k g ) [33], b u t no  ch an g e  p lasm a an tio x id an t p o w er o r u rin ary  
iso p ro stan es  in  qu erce tin  su p p lem en ted  hu m an s (~8.1 m g q u erce tin /k g ) [37]. In  these  stud ies w e 
ach iev ed  p lasm a q u erce tin -m etab o lite  leve ls  3 .96  |ig /m L  in  ra ts, b u t on ly  0 .48 jag/m L in  hum ans. 
T h ere fo re  it is p o ssib le  th a t the  d isp ara te  e ffec ts  on ox id a tiv e  stress w ere  due to  the  d ram atic  
d iffe ren ce  in  tissu e  /  ce llu la r q u erce tin  co n cen tra tio n s . G iven  the  in co n sis ten t ev id en ce  reg ard in g  
q u e rce tin ’s an tio x id an t e ffec ts , it is p o ss ib le  th a t the  B P  lo w erin g  e ffec t o f  q u erce tin  m ay  be due to 
o th er m ore  do m in an t m echan ism s. H ow ever, fu rth e r in v estig a tio n  o f  the  an tio x id an t cap ac ity  o f 
qu erce tin  and  its  m etab o lites  in  hu m an s m ay  e lu c id a te  w h e th e r o r n o t a lo ca lized  an tio x id an t e ffec t 
(e .g ., a t the  en d o th eliu m ) m ay  p lay  a ro le  in  B P  reduction .
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4.2. Rennin-Angiotensin System
T h e R A S (F igure  4) is in v o lv ed  in  the  reg u la tio n  o f  B P  and  co n tro ls  flu id  loss. L o n g -te rm  o v er­
ac tiv a tio n  o f  the  R A S  is asso c ia ted  w ith  h y p erten sio n  and  can  hav e  n eg a tiv e  ca rd io v ascu la r e ffec ts  [9]. 
In te rfe ren ce  w ith  the  R A S  by  p h arm aco lo g ica l A C E  in h ib ito rs  such  as cap to p ril and  im id ap ril can  
red u ce  c ircu la tin g  an g io ten sin  II, a p o ten t v aso co n stric to r, re su ltin g  in  lo w er b lo o d  p ressu re  and  few er 
ca rd io v ascu la r even ts  in  h ig h -risk  p o p u la tio n s  [1,10]. P h arm aco lo g ica l in h ib ito rs , such  as cap to p ril 
and  im idapril, in ac tiv a te  the  A C E  m o lecu le  v ia  b in d in g  a z inc m o lecu le  a t the  ac tiv e  site and  slow  the 
co n v ersio n  o f  an g io ten sin  I to  an g io ten sin  II [5 ,41]. Som e flav o n o id s  are also  k n o w n  to b in d  m etal 
ions, such  as zinc. Q u erce tin  is p articu la rly  k n o w n  fo r th is  p ro p e rty  [36] and  th ere  is ev id en ce  tha t 
qu erce tin  m ay  in h ib it A C E  ac tiv ity  v ia  th is  m ech an ism  [42].
F ig u re  4 . T h e  re n in -an g io ten s in  system  (R A S).
T h e  h y p o th esis  th a t qu erce tin  m ig h t red u ce  B P  via  A C E  in h ib itio n /a tten u a tio n  has b een  tes ted  in  
an im al m odels. H ack le  et al. [32] ex am in ed  the acu te  e ffec ts  o f  o ra l and  in trav en o u s (IV ) qu erce tin  
and  cap to p ril ad m in is tra tio n  on the  B P  re sp o n ses  to  b rad y k in in  and  an g io ten sin  1 in fu sio n  in  
n o rm o ten siv e  W is ta r ra ts. B rad y k in in -ev o k ed  h y p o ten sio n  w as p o ten tia ted  by  cap to p ril and  qu erce tin
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b u t n o t p lacebo  trea tm en t. M o reo v er, an g io ten sin  1 -induced  h y p erten sio n  w as b lu n ted  by  cap to p ril and 
qu erce tin  b u t n o t p laceb o  trea tm en t (p <  0 .05). In  th is  study  au tho rs rep o rted  a 31%  decrease  in  A C E  
ac tiv ity  a fte r q u erce tin  trea tm en t vs. b ase lin e  [32], suggesting  th a t qu erce tin  ac ted  as an  A C E  inh ib ito r. 
W h ile  th is  is a s ig n ifican t find ing , it is d ifficu lt to  de term ine  the  re la tiv e  “ s treng th” o f  q u e rce tin ’s A C E  
in h ib ito ry  e ffec t since there  w as no d irec t co m p ariso n  m ad e  ag a in st cap to p ril ev o k ed  A C E  in h ib itio n  
in  th is  study.
M ackraj et al. [34] also  co m p ared  the  an tih y p erten siv e  e ffec ts  o f  cap to p ril to  qu erce tin  u sing  D ahl 
sa lt sensitive  ra ts  w h ich  w ere  separa ted  in to  th ree  g ro u p s and  in jec ted  d a ily  fo r 4  w eek s w ith  cap top ril, 
querce tin , o r p lacebo . B P  dec reased  sim ilarly  in  cap to p ril and  q u erce tin  trea ted  g ro u p s and  in creased  
in  the  un trea ted  co n tro l g roup  (p <  0 .05). C ap to p ril and  q u erce tin  trea ted  g ro u p s also  show ed  dow n- 
reg u la tio n  o f  the  A T1 recep to r in  the  k id n ey  w h en  co m p ared  to  the  u n trea ted  g roup  (p <  0 .05) [34]. 
T ak en  together, th ese  da ta  in d ica te  th a t ch ro n ic  qu erce tin  su p p lem en ta tio n  m ig h t red u ce  B P  in  a salt 
sensitive  m o d el o f  h y p erten sio n  th ro u g h  m o d u la tio n  o f  ren a l fu n c tio n  and  A T1 recep to r transcrip tion . 
H ow ever, b ecau se  A C E  ac tiv ity  w as n o t assessed  in  th is s tudy  it is u n c lea r w h e th e r q u erce tin  ac ted  as 
an  A C E  in h ib ito r as w ell. T he m ech an ism  fo r B P  red u c tio n  is likely  to  have  been  a re su lt o f  dow n- 
reg u la tio n  o f  A T  1a ex p ress io n  in  the  k idney . W h ile  th is  m ech an ism  m ay  ex p la in  the  h y p o ten siv e  
e ffec t o f  ch ro n ic  qu erce tin  supp lem en ta tio n , it is un lik e ly  to  ex p la in  the  acu te  red u c tio n s  in  B P  seen  by 
H ack le  et al.
G iven  the  ev id en ce  in  an im als th a t in d ica tes  qu erce tin  m ay  ac t as an  A C E  in h ib ito r and  can  red u ce  
A T  1a ex p ressio n , it is p o ssib le  th a t s im ilar m ech an ism s m ig h t be  re sp o n sib le  fo r red u c tio n s  in  B P  
ob serv ed  in  h u m an  stud ies. H o w ev er, no  p u b lish ed  re search  ex is ts  reg ard in g  e ith e r p o ssib ility . In  lig h t 
o f  the  p ro v en  e fficacy  o f  p h arm aco lo g ica l A C E  in h ib ito rs  in  h um ans, th ere  is a n eed  to  co n d u c t 
c lin ica l tria ls  to d e term in e  w h e th e r q u erce tin -in d u ced  decreases in  A C E  ac tiv ity  m ig h t be  resp o n sib le  
fo r  the  B P  lo w erin g  effec ts  th is flav o n o id  exerts  in  h y p erten siv e  hum ans.
4.3. Vascular Function
E n d o th e lia l ce lls  line the  w alls  o f  the  a rte rio les  and  p lay  a v ery  im p o rtan t ro le  in  m ain ta in ing  
v ascu la r h o m eo stasis , v ascu la r tone, ca rd io v ascu la r and  m icro v ascu la r health . E n d o th e lia l d y sfu n c tio n  
is a c ritica l ev en t in  the  p a th o g en esis  o f  C V D  and  an in d ep en d en t p red ic to r o f  ca rd io v ascu la r ev en ts  
[43]. It is a com m o n  fea tu re  in  a ll fo rm s o f  C V D , in c lu d in g  h y p erten sio n  [43,44]. T he en d o th e liu m  
re leases  a v arie ty  o f  vaso ac tiv e  substances such  as n itric  ox ide  (N O ) and  endo thelin -1  (E T -1), w h ich  
serve, in  part, to  reg u la te  B P  and  b lo o d  flo w  [2 ,4 ,43 ,45 ,46 ]. A  co m m o n  fea tu re  o f  en d o th elia l 
d y sfu n c tio n  is d im in ish ed  b io av a ilab ility  o f  the  v aso d ila to r N O  w h ich  re su lts  in  less en d ogenous 
o p p o sitio n  to  c ircu la tin g  v aso co n stric to rs  such  as E T -1 [4]. N O  and  E T -1 ap p ear to  have  a rec ip ro ca l 
reg u la tio n ; as N O  b io av a ilab ility  d ecreases  th ere  is en h an ced  syn thesis  o f  ET-1 [4]. E n d o th e lia l 
d y sfu n c tio n  is rev e rs ib le  and  in te rv en tio n s th a t red u ce  r isk  fo r C V D , such as ex e rc ise  and 
p h arm aceu tica ls , can  also  im p ro v e  en d o th e lia l fu n c tio n  [4]. F o r th is reaso n , it h as  b eco m e a su rrogate  
b io m ark e r and  en d p o in t fo r  d eterm in ing  e fficacy  o f  C V D  in te rv en tio n s [4,47].
E n d o th e liu m -d ep en d en t v aso re lax a tio n  and  p ro p e r en d o th e lia l fu n c tio n  is la rge ly  d ep en d en t on  the 
p ro d u c tio n  and  b io av a ilab ility  o f  N O . D ue to  its  sh o rt h a lf-life  N O  is very  d ifficu lt to  assess in vivo. 
In d irec t m easu rem en ts  o f  N O , such  as flo w  m ed ia ted  d ila tio n  (F M D ) and  co n cen tra tio n  o f  N O
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m etab o lites  (n itrites and  n itra tes) can  be  u sed  to  estim ate  en d o g en o u s p ro d u c tio n  [26,30]. F M D  in  the 
p erip h e ra l c ircu la tio n  is p rim arily  m ed ia ted  by  en d o th e liu m -d eriv ed  N O  in  re sp o n se  to  in c reased  flow  
and  shear stress, and  re su lts  in  sm ooth  m u scle  re lax a tio n  and  arte ria l d ila tio n  [4,46].
P rev io u s stud ies u sing  an im al m o d els  hav e  show n  th a t q u erce tin  in d u ced  red u c tio n s in  B P  
are acco m p an ied  b y  im p ro v em en ts  in  en d o th e lia l fu n c tio n  and  b io m ark e rs  o f  en d o th e lia l 
fu n c tio n  [2 9 -3 1 ,3 6 ]. F o r ex am p le , D u arte  et al. [29] fo u n d  th a t qu erce tin  red u ced  B P  in  SH R , and 
im p ro v ed  en d o th e liu m -d ep en d en t v aso re lax a tio n  o f  iso la ted  aorta . In  an o th er study, D u arte  et al. [31] 
ad m in is te red  the  N O  syn thase  (N O S) inh ib ito r, L -N A M E , to  the  d rink ing  w a te r o f  ra ts  cau sin g  th em  to 
b eco m e hyp erten siv e . R ats  trea ted  w ith  q u erce tin  ex h ib ited  less severe  L -N A M E -in d u ced  h y p erten sio n  
and  en d o th e liu m -d ep en d en t d y sfu n c tio n  o f  arte ries. S im ilarly , Y am am o to  et al. [30] u sed  a d ie tary  
m o d el o f  h y p erten sio n  (h igh-fa t, h ig h -su cro se  d ie t fo r  4 -w eek s), and  rep o rted  th a t system ic 
h y p erten sio n , red u ced  aortic  N O S  ac tiv ity , and  d ecreased  u rin ary  N O  m etab o lites  w ere  am elio ra ted  in  
ra ts  th a t co n cu rren tly  co n su m ed  querce tin . T ak en  to g e th er th ese  stud ies in d ica te  th a t qu erce tin  can  
im p ro v e  en d o th e lia l fu n c tio n  v ia  in creasin g  N O  b io av a ilab ility  an d /o r N O  p ro d u c tio n , and  th a t these  
im p ro v em en ts  m ay  be re sp o n sib le  fo r red u c tio n  o f  B P.
A  recen t s tudy  by  L oke et al. [26], co n d u c ted  in  h um ans, rep o rted  th a t q u erce tin  has the  p o ten tia l to 
im p ro v e  the  b a lan ce  b e tw een  c ircu la tin g  E T -1 and  N O . H ealthy , n o rm o ten siv e  m ales w ere  g iv en  a 
sing le  200 m g dose o f  qu erce tin  o r p lacebo ; a fte r 2 hours, p lasm a E T -1 w as lo w er and  a fte r 5 h  u rinary  
m etab o lites  o f  N O  w ere  h ig h e r in  qu erce tin  vs. p lacebo  trea tm en t. T h ere  w ere  no  ch an g es in  
m easu rem en ts  o f  ox id a tiv e  stress. W h ile  B P  w as n o t m easu red  in  th is  study , th ese  d ata  p ro v id e  p ro o f 
o f  p rin c ip le  th a t qu erce tin  has p o ten tia l to  b en e fic ia lly  a lte r en d o th e lia l fu n c tio n  and  v a scu la r tone.
F M D  in  hum ans h as  been  ex am in ed  a fte r the  ch ro n ic  and  acu te  co n su m p tio n  o f  fo o d s and  
b ev e rag es  very  h ig h  in  flavono ids. In  a p laceb o -co n tro lled , c ro sso v e r study, u sing  p a rtic ip an ts  w ith  
co ro n ary  arte ry  d isease  (n = 50), V ita  et al. [47] found  acu te  and  ch ro n ic  te a  co n su m p tio n  im p ro v ed  
F M D , w ith o u t an  e ffec t on  n itro g ly cerin -m ed ia ted  d ila tion , co m p ared  to  p lacebo  (P <  0 .05). B ecau se  
F M D  w as n o t in flu en ced  by  an acu te  dose  o f  ca ffe in e , im p ro v em en ts  w ere  n o t secondary  to th is 
co m p o n en t o f  tea. N o m ark ers o f  ox id a tiv e  stress w ere  a ltered , suggesting  th a t im p ro v em en ts  w ere  no t 
due to  an  an tio x id an t e ffec t [47]. S ince B P  w as n o t assessed  in  th is  s tudy  it is u n c lea r w h e th e r F M D  
im p ro v em en ts  re su lted  in  b en e fic ia l h em o d y n am ic  a ltera tions. G iven  th a t tea  co n ta in s  an  asso rtm en t o f  
p o ly p h en o lic  co m pounds, in c lu d in g  querce tin , it  is d ifficu lt to  ascerta in  i f  the  im p ro v em en t in  
en d o th e lia l fu n c tio n  w as due to  a sing le d o m in an t in g red ien t, such  as q u erce tin , o r due to  the 
synerg istic  ac tio n  o f  co m b in ed  p o ly p h en o lic  com pounds. T h ese  fin d in g s are sim ilar to  o th er stud ies 
th a t have  ex am in ed  the  b en efits  o f  flav o n o id -rich  fo o d s on en d o th e lia l fu n c tio n  [25]. A lth o u g h  
qu erce tin  is an  ab u n d an t flav o n o id  and  p resen t in  the  fo o d s and  b ev e rag es  ex am in ed  in  the  p rev io u s 
stud ies, ch an g es in  F M D  so le ly  as a re su lt o f  acu te  o r  ch ro n ic  q u erce tin  ad m in is tra tio n  have  n o t yet 
b een  assessed . L ikew ise , it is u n k n o w n  w h e th e r q u erce tin -in d u ced  im p ro v em en ts  in  en d o th e lia l 
fu n c tio n — should  th ey  occu r— w ill re su lt in  a red u c tio n  o f  B P  in  hum ans.
T h ere  is a lso  ev id en ce  th a t supports a ro le  fo r qu erce tin  to  a lte r gen e  ex p ressio n  [3 ,3 4 ,4 8 -5 0 ]. 
N ich o lso n  et al. [48] in v estig a ted  the  e ffec ts  o f  q u erce tin  on g en e  ex p ress io n  in  h u m an  um b ilica l vein  
en d o th e lia l ce lls  (H U V E C ) and  fo u n d  q u erce tin  d o w n -reg u la ted  ET -1 ex p ressio n  sign ifican tly . Z hao  
et al. [50] also  fo u n d  a d o se-d ep en d en t decrease  in  E T -1 re lease  a fte r ex vivo  ad m in is tra tio n  o f 
qu erce tin  in  H U V E C . T h ese  fin d in g s p ro v id e  su pport fo r  the  h y p o th esis  th a t qu erce tin  m ig h t red u ce
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E T -1 and  th ereb y  im p ro v e  v ascu la r fu n c tio n  by  a ltering  the  b a lan ce  b e tw een  c ircu la tin g  co n stric to r 
and  d ila to r substances. A d d itio n a l re search  is n eed ed  to  co n firm  th a t th ese  fin d in g s tran sla te  to  hum ans 
in vivo.
4 .4 . D irect A ction  on the Vascular Sm ooth M uscle
T h ere  is also  ev id en ce  th a t qu erce tin  m ay  red u ce  B P  th ro u g h  m ech an ism s in d ep en d en t o f  the 
en do thelium . F o r exam ple , qu erce tin  h as b een  show n to ev o k e  v aso re lax a tio n  in  en d o th e lia l-d en u d ed  
vesse ls , suggesting  th a t th is  flav o n o id  can  ac t d irec tly  on the  v ascu la r sm ooth  m u scle  
(V S M ) [35 ,36 ,51]. In  ad d itio n  to the  p aren t flav o n o id , m etab o lites  o f  qu erce tin  also  m ig h t ac t d irec tly  
on  V S M . P erez-V izca in o  et al. [35] rep o rted  qu erce tin  and  iso rh am n etin  (querce tin  m etabo lite) 
in d u ced  v aso re lax a tio n  o f  ra t ao rtic  rin g s sim ilarly  reg ard less  o f  w h e th e r the  en d o th e lia l lay e r o f  
v esse ls  w as in tac t o r denuded . L ikew ise , R end ig  et al. [51] found  th a t the  en h an ced  v aso re lax a tio n  in  
re s is tan ce  and  co n d u c tan ce  rab b it v esse ls  a fte r qu erce tin  trea tm en t w as in d ep en d en t o f  the  p resen ce  o f 
the  en do thelium . I t shou ld  be  n o ted  th a t s ince these  stud ies u sed  n o rm o ten siv e  an im als and  d id  no t 
assess B P , a co m p ariso n  ag a in st p rev io u sly  m en tio n ed  fin d in g s is d ifficu lt. H o w  q u erce tin  acts on  the 
V S M  is n o t clear, b u t it has been  specu la ted  th a t v aso d ila tio n  m ay  re su lt from  in h ib itio n  o f  p ro te in  
k in ases  in v o lv ed  in  the  C a2+ sensitiz ing  m ech an ism s re sp o n sib le  fo r  sm ooth  m u scle  co n trac tio n  [35]. 
T h e  e ffec t o f  qu erce tin  on  the  V S M  o f  h u m an s is unclea r. F M D  stud ies in d ica te  th a t fo o d s h ig h  in  
qu erce tin  im p ro v e  en d o th e liu m -d ep en d en t v aso d ila tio n  b u t do n o t e ffec t en d o th e liu m -in d ep en d en t 
d ila tio n  [47]; how ever, th is  has y e t to  be  ex am in ed  in  tria ls  in v o lv in g  qu erce tin  supp lem entation .
5. S a fe ty  o f  Q u e rc e t in
Q u erce tin  is b e liev ed  to  be  an tim u tag en ic  in vivo  and  lo n g -te rm  stud ies have  fo u n d  th a t qu erce tin  is 
n o t ca rc in o g en ic  [52]. V ery  few  n eg a tiv e  side e ffec ts  hav e  been  n o ted  w ith  sho rt-te rm  (<3 m onths), 
h ig h  in tak es o f  qu erce tin  [19 ,37 ,38], b u t th ere  have  b een  rep o rts  o f  nausea , headache , and  tin g lin g  o f 
the  ex trem ities  w ith  ch ro n ic  q u erce tin  su p p lem en ta tio n  o f  1,000 m g /d ay  (as rev iew ed  by  H arw o o d  
et al. [52]). O u r stud ies to  date  w ith  hum ans, in c lu d in g  re search  in  p rog ress, h av e  n o t fo u n d  any  
ad v erse  side effec ts  w ith  ch ro n ic  doses o f  7 30  m g /d ay  fo r 28 days, o r an  acu te  dose  o f  1,095 m g 
qu erce tin  ag lycone  in  hum ans [37]. Q u erce tin  is also  an  in h ib ito r o f  C Y P 3A 4, an  en zy m e th a t b reaks 
dow n  m an y  co m m o n ly  p resc rib ed  d rugs in  the  body ; there fo re , qu erce tin  shou ld  n o t be tak en  w ith  
drugs th a t d ep en d  on  th is en zy m e fo r m etabo lism . S ince m an y  flav o n o id s  h av e  b een  fo u n d  to  in h ib it 
p la te le t ag g reg a tio n  (v ia  in h ib itio n  o f  th ro m b o x an e  A 2) [3 ,47], it is also  p o ssib le  th a t p h arm aco lo g ica l 
doses o f  qu erce tin  co u ld  in crease  risk  o f  b leed in g  w hen  tak en  w ith  an tico ag u lan t drugs.
6 . C o n c lu s io n s
D esp ite  the  u n ce rta in ty  o f  q u e rce tin ’s m ech an ism  o f  ac tion  o f  B P  red u c tio n  in  h um ans, it ho lds 
p ro m ise  fo r  the  trea tm en t o f  h y p erten sio n  and  p ro m o tin g  ca rd io v ascu la r hea lth . In vitro  and  in vivo  
re search  in  an im al m o d els has show n m u ltip le  m ech an ism s o f  ac tio n  th a t co u ld  p ro d u ce  the  B P  
lo w erin g  e ffec t seen  in  h y p erten siv e  hum ans. In  co n ju n c tio n  w ith  id en tify in g  p rim ary  m echan ism s, 
m ore  co n tro lled  ran d o m ized  h u m an  re search  stud ies are n eed ed  to  co n firm  q u e rce tin ’s efficacy ,
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m ag n itu d e  o f  e ffec t, and  o p tim al dosing  schedu le . F u rth erm o re , it needs to  be d e term in ed  i f  qu erce tin  
is an  e ffec tiv e  trea tm en t fo r all fo rm s o f  h y p erten sio n  reg ard less  o f  p a th o lo g ica l o rig in . S tudies 
in c lu d in g  d iffe ren t e th n ic ities  and  w o m en  are still scarce  and  lo n g -te rm  stud ies ex am in in g  the  safe ty  o f 
qu erce tin  su p p lem en ta tio n  need  to  be co n d u c ted  b efo re  reco m m en d in g  th is  flav o n o id  as a trea tm en t 
op tion  fo r the  public .
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